SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-18-000094
Filing Date
2018-08-16
Accepted
2018-08-16 07:11:26
Documents
1
Period of Report
2018-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_153441787053493.html 4  
1 FORM 4 wf-form4_153441787053493.xml 4 3653
  Complete submission text file 0001114220-18-000094.txt   5017
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KERYX BIOPHARMACEUTICALS INC 1 MARINA PARK DR., 10TH FLOOR BOSTON MA 02210
Business Address
Holmes Scott A (Reporting) CIK: 0001537670 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 181022297